Abstract: Annals of the New York Academy of SciencesVolume 712, Issue 1 p. 301-314 Immunomodulation by Didemnins Invertebrate Marine Natural Products DAVID W. MONTGOMERY, DAVID W. MONTGOMERY Department of Surgery, University of Arizona College of Medicine Tucson, Arizona 85742 Department of Pharmacology University of Arizona College of Medicine Tucson, Arizona 85742 Department of Veterans Affairs Medical Center Tucson, Arizona 85723Search for more papers by this authorGARY K. SHEN, GARY K. SHEN Department of Surgery, University of Arizona College of Medicine Tucson, Arizona 85742Search for more papers by this authorELLEN D. ULRICH, ELLEN D. ULRICH Department of Veterans Affairs Medical Center Tucson, Arizona 85723Search for more papers by this authorCHARLES F. ZUKOSKI, CHARLES F. ZUKOSKI Department of Surgery, University of Arizona College of Medicine Tucson, Arizona 85742 Department of Veterans Affairs Medical Center Tucson, Arizona 85723Search for more papers by this author DAVID W. MONTGOMERY, DAVID W. MONTGOMERY Department of Surgery, University of Arizona College of Medicine Tucson, Arizona 85742 Department of Pharmacology University of Arizona College of Medicine Tucson, Arizona 85742 Department of Veterans Affairs Medical Center Tucson, Arizona 85723Search for more papers by this authorGARY K. SHEN, GARY K. SHEN Department of Surgery, University of Arizona College of Medicine Tucson, Arizona 85742Search for more papers by this authorELLEN D. ULRICH, ELLEN D. ULRICH Department of Veterans Affairs Medical Center Tucson, Arizona 85723Search for more papers by this authorCHARLES F. ZUKOSKI, CHARLES F. ZUKOSKI Department of Surgery, University of Arizona College of Medicine Tucson, Arizona 85742 Department of Veterans Affairs Medical Center Tucson, Arizona 85723Search for more papers by this author First published: April 1994 https://doi.org/10.1111/j.1749-6632.1994.tb33580.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Rinehart, K. L., Jr., J. B. Gloer, J. C. Cook, S. A. Mizak & T. A. Scahill. 1981. Structures of the didemnins, antiviral and cytotoxic depsipeptides from a Caribbean tunicate. J. Am. Chem. Soc. 103: 1857– 1859. 2 Rinehart, K. L., Jr., J. B. Gloer, R. G. Hughes, Jr., H. E. Renis, J. P. McGovern, E. B. Swynenberg, D. A. Stringfellow, S. L. Kuentzel, & L. H. Li. 1981. Didemnins: Antiviral and antitumor depsipeptides from a Caribbean tunicate. Science 12: 933– 935. 3 Rinehart, K. L., Jr., J. B. Gloer, G. R. Wilson, R. G. Hughes, Jr., L. H. Li, H. E. Renis & J. P. McGovern. 1983. Antiviral and antitumor compounds from tunicates. Fed. Proc. 42: 87– 90. 4 Jiang, T. L., R. H. Liu & S. E. Salmom. 1983. Antitumor activity of didemnin B in the human tumor stem cell assay. Cancer Chemother. Pharmacol. 11: 1– 4. 5 Montgomery, D. W. & C. F. Zukoski. 1985. Didemnin B: A new immunosuppressive cyclic peptide with potent activity in vitro and in vivo. Transplantation 40: 49– 56. 6 Teunissen, M. B. M., F. H. M. Pistoor, H. A. H. Rongen, M. L. Kapsenberg & J. D. Bos. 1992. A comparison of the inhibitory effects of immunosuppressive agents cyclo-sporine, tetranactin, and didemnin B on human T-cell responses in vitro. Transplantation 53: 875– 881. 7 LeGrue, S. J., T. C. Sheu, D. D. Carson, J. L. Laidlae & S. K. Sanduja. 1988. Inhibition of T-lymphocyteproliferation by the cyclic polypeptide didemnin B: No inhibition of lymphokine stimulation. Lymphokine Res. 7: 21– 29. 8 Russell, D. H., A. R. Buckley, D. W. Montgomery, N. A. Larson, P. W. Gout, C. T. Beer, C. W. Putnam, C. F. Zukoski & R. A. Kibler. 1987. Prolactin-dependent mitogenesis in Nb2 node lymphoma cells: Effects of immunosuppressive cyclopeptides. J. Immunol. 138: 276– 284. 9 Alfrey, E. J., C. F. Zukoski & D. W. Montgomery. 1992. Didemnin B prolongs survival of mouse skin allografts. Transplantation 54: 188– 189. 10 Yuh, D. D., R. P. Zurcher & R. E. Morris. 1989. Efficacy of didemnin B in suppressing allograft rejection in mice and rats. Transplant. Proc. 21: 1141– 1143. 11 Stevens, D. W., R. M. Jensen & L. E. Stevens. 1989. Didemnin B prolongs rat heart allograft survival. Transplant. Proc. 21: 1139– 1140. 12 Montgomery, D. W., A. Cwelniker & C. F. Zukoski. 1987. Didemnin B—an immunosuppressive cyclic peptide that stimulates murine hemagglutinating antibody responses and induces leukocytosis in vivo. Transplantation 43: 133– 139. 13 Crampton, S. L., E. G. Adams, S. L. Kuentzel, L. H. Li, G. Badiner & B. K. Bhuyan. 1984. Biochemical and cellular effects of didemnins A and B. Cancer Res. 44: 1796– 1801. 14 Gschwendt, M., W. Kittstein & F. Marks. 1987. Didemnin B inhibits biological effects of tumor-promoting phorbol esters on mouse skin, as well as phosphorylation of a 100-kD protein in mouse epidermis cytosol. Cancer Lett. 34: 187– 191. 15 Shen, G. K., C. F. Zukoski & D. W. Montgomery. 1992. A specific binding site in Nb2 node lymphoma cells mediates the effects of didemnin B, an immunosuppressive cyclic peptide. Int. J. Immunopharmacol. 14: 63– 73. 16 Schreiber, S. L. 1991. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 251: 283– 287. 17 Montgomery, D. W., G. K. Shen, E. D. Ulrich, L. L. Steiner, P. R. Parrish & C. F. Zukoski. 1992. Human thymocytes express a prolactin-like messenger ribonucleic acid and synthesize bioactive prolactin-like proteins. Endocrinology 131: 3019– 3026. 18 Scatchard, G. 1949. The attraction of proteins for small molecules and ions. Ann. N.Y. Acad. Sci. 51: 660– 672. 19 Handschumacher, R. E., M. W. Harding, J. Rice & R. J. Drugge. 1984. Cyclophilin: A specific cytosolic binding protein for cyclosporine A. Science 226: 544– 547. 20 Phillips, J. L., R. Schwartz & D. D. Von Hoff. 1989. In vitro distribution of diacetyl didemnin B in human blood cells and plasma. Cancer Invest. 7: 123– 128. 21 Rosen, M. K., R. F. Standqaert, A. Galat, M. Nakatsuka & S. L. Schreiber. 1990. Inhibition of FKBP rotamase activity by immunosuppressant FK506: Twisted amide surrogate. Science 248: 863– 866. 22 Hossain, M. B., D. Helm, J. Van Der Antel, G. M. Sheldrick, S. K. Sanduja & A. J. Weinheimer. 1988. Crystal and molecular structure of didemnin B, an antiviral and cytotoxic depsipeptide. Proc. Natl. Acad. Sci. USA 85: 4118– 4122. 23 Schreiber, S. L. & G. R. Crabtree. 1992. The mechanisms of action of cyclosporine A and FK506. Immunol. Today 13: 136– 141. 24 Sigal, N. H. & F. J. Dumont. 1992. Cyclosporine A, FK-506, and rapamycin: Pharmacologic probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10: 519– 560. Citing Literature Volume712, Issue1Primordial Immunity: Foundations for the Vertebrate Immune SystemApril 1994Pages 301-314 ReferencesRelatedInformation
Publication Year: 1994
Publication Date: 1994-04-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 8
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot